Clinical Trials · NCT07156539
A Phase 3 Study of HS-20094 in Patients With T2DM
- Phase
- Phase 3
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Enrollment
- 546
- Start date
- Sep 2025
- Locations
- 2 sites, China
- Primary endpoint
- Change in HbA1c